Fellowship in Pediatric Infectious Disease at Cohen Children’s Medical Center
The fellowship in pediatric infectious diseases at Cohen Children’s Medical Center is designed to train the fellow in the entire clinical spectrum of infectious diseases, to provide training in clinical microbiology, and to provide the opportunity to design and carry out basic and/or clinical investigative projects related to infectious diseases.
During the training program, the fellow performs clinical consultations on inpatients and outpatients, participates in infectious diseases conferences and journal clubs, and prepares and delivers lectures to the pediatric staff house. The outpatient experience includes participation in the Pediatric Travel and Immunization Service.
Additionally, fellows spend at least one month in the clinical microbiology laboratory learning the principles and techniques of diagnostic bacteriology, virology, serology, and molecular diagnostics.
Fellows spend one month on inpatient service with the Division of Infectious Diseases of the Department of Internal Medicine. Fellows attend continuity clinic for up to 24 months with the Pediatric Immunology Division at the Children’s Hospital where they gain experience with diagnosing and managing children with immune deficiency disorders and the management of HIV-infected children. Each fellow is enrolled in a course on research techniques and introduction to biostatistics. First year fellows spend at least six months on the clinical consultative services. The majority of the second and third years of fellowship is devoted to clinical and/or laboratory research.
Fellows rotate through Cohen Children's Medical Center in New Hyde Park and North Shore University Hospital in Manhasset. The research facility is the Feinstein Institute for Medical Research. All are components of Northwell Health. The patient population includes walk-in, primary care patients, but has a major tertiary and quaternary care patient population including a large number of hematology-oncology patients, neonatal and pediatric intensive care patients, and children with congenital heart disease. Special programs include stem cell transplantation, ECMO, and cystic fibrosis.
Applicants interested in the pediatric infectious disease training program at Cohen Children’s Medical Center should apply through the Electronic Residency Application Service (ERAS). Completion of an ACGME-accredited residency program in general pediatrics is mandatory for admission to this program.
Essential application information includes:
- Universal application
- Personal statement
- At least three (3) letters of recommendation. Letters of recommendation must be less than six (6) months old.
- USMLE or COMLEX transcript
- Medical school transcript
- Updated curriculum vitae
- Letter of recommendation from program director
Only applicants who have passed USMLE examination STEP 1 and 2 on the first attempt should apply. Only completed applications with all supporting documentation will be reviewed.
About the team
Lorry Rubin, MD, is director of Pediatric Infectious Diseases Fellowship Program and chief of the Division of Infectious Diseases at Cohen Children's Medical Center. He is also a professor of Pediatrics at Albert Einstein College of Medicine. Dr. Rubin serves as a consultant to the Committee on Infectious Diseases of the American Academy of Pediatrics (“Red Book Committee”). His main research interests are in the areas of bacterial pathogenicity including the pathogens streptococcus pneumoniae and haemophilus influenzae; the pathogenesis, prevention and treatment of the catheter-associated bacteremia; and infection control and prevention.
Sunil Sood, MD, is the chair of Pediatrics Infectious at Southside Hospital. His research interests are treatment of congenital cytomegalovirus (CMV) infection; anti-viral treatment of serious influenza infection; and diagnosis, prevention and pathogenesis of Lyme disease.
The research interests of Sujatha Rajan, MD, are in prevention, diagnosis and treatment of fungal infections and infections in stem cell transplant recipients.